Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Owen Bowden-Jones , Dima AbdulrahimPublisher: RCPsych/Cambridge University Press Imprint: RCPsych/Cambridge University Press Dimensions: Width: 12.20cm , Height: 0.70cm , Length: 18.60cm Weight: 0.160kg ISBN: 9781911623090ISBN 10: 1911623095 Pages: 150 Publication Date: 08 October 2020 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsReviews'This book is an invaluable resource in a fast changing and baffling field of psychiatry. It provides an up-to-date, evidence-based guide by leading experts to all you need to know to provide care for those suffering the mental health consequences of novel psychoactive drugs.' Adrian James, President, Royal College of Psychiatrists 'A very nice reading; very easy to follow and with a clear focus on the clinical issues, e.g. what the practicing clinician … need to know to interact with the client; to make a diagnosis; and identify a proper treatment and management approach. Although the language and the tones here used are straightforward and direct, the content of the document is precise, really updated, and definitely non-judgmental. I particularly enjoyed reading the clinical vignettes; they illustrate a range of complex issues in a way which is simple enough for even the non experienced clinician/non experienced trainee to be able to understand. There are a few sections, e.g. the one on psychedelic phenethylamines and GHB, which are of particular value. The focus on GHB withdrawal is important and detailed.' Fabrizio Schifano, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, University of Hertfordshire 'This book is an invaluable resource in a fast changing and baffling field of psychiatry. It provides an up-to-date, evidence-based guide by leading experts to all you need to know to provide care for those suffering the mental health consequences of novel psychoactive drugs.' Adrian James, President, Royal College of Psychiatrists 'A very nice reading; very easy to follow and with a clear focus on the clinical issues, e.g. what the practicing clinician ... need to know to interact with the client; to make a diagnosis; and identify a proper treatment and management approach. Although the language and the tones here used are straightforward and direct, the content of the document is precise, really updated, and definitely non-judgmental. I particularly enjoyed reading the clinical vignettes; they illustrate a range of complex issues in a way which is simple enough for even the non experienced clinician/non experienced trainee to be able to understand. There are a few sections, e.g. the one on psychedelic phenethylamines and GHB, which are of particular value. The focus on GHB withdrawal is important and detailed.' Fabrizio Schifano, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, University of Hertfordshire Author InformationOwen Bowden-Jones is Consultant in Addiction Psychiatry and Founder of the CNWL Club Drug Clinic, London, and Honorary Professor at University College London. He is Chair of the Advisory Council on the Misuse of Drugs and National Clinical Adviser to the Alcohol, Drugs and Tobacco division at Public Health England. Dima Abdulrahim is Programme Manager and Principal Researcher for the NEPTUNE Project for the Club Drug Clinic, Central and North West London NHS Foundation Trust. She has been working in the drug treatment field for over 30 years. Tab Content 6Author Website:Countries AvailableAll regions |
||||
